Diabetes Clinical Trials in Cleveland, OH

30 recruiting studies within 50 miles

Phase

Trial	Phase	Sponsor	Dist.
North American Mitochondrial Disease Consortium Patient Registry and Biorepository (NAMDC)	—	Columbia University	<1 mi
Exciflex for Chronic Wound Therapy	N/A	VA Office of Research and Development	<1 mi
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes	N/A	Medtronic Diabetes	<1 mi
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone	N/A	Capsicure, LLC	<1 mi
A Study to Test Whether BI 764524 Helps People With an Eye Condition Called Diabetic Retinopathy	Phase 2	Boehringer Ingelheim	<1 mi
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma	Phase 2	Children's Oncology Group	<1 mi
Promoting Alternatives to Sulfonylureas to Improve Patient Safety in Type 2 Diabetes	N/A	Ian J. Neeland, MD	<1 mi
KHENERFIN Study: A Trial to Evaluate the Efficacy and Safety of Sonlicromanol in Primary Mitochondrial Diseases	Phase 3	Khondrion BV	<1 mi
A Research Study to See How a Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine, Both in Combination With Insulin Aspart, in Adults With Type 1 Diabetes	Phase 3	Novo Nordisk A/S	<1 mi
Utilizing Community Health Workers as Diabetes Technology Coaches for Children With Type 1 Diabetes Using Automated Insulin Delivery	N/A	University Hospitals Cleveland Medical Center	<1 mi
RESET System Pivotal Trial (Rev F)	N/A	Morphic Medical Inc.	<1 mi
Monocytes in Subjects With Type 1 Diabetes and Chronic Kidney Disease	—	The Cleveland Clinic	<1 mi
Registry for Stage 2 Type 1 Diabetes	—	Sanofi	<1 mi
Impact of Per Oral Pyloromyotomy (POP) on Glycemic Control in Diabetes	N/A	Matthew Allemang	<1 mi
Transverse Tibial Transport for Chronic Limb-Threatening Ischemia (CLTI)	N/A	University Hospitals Cleveland Medical Center	<1 mi
Fenofibrate for Prevention of DR Worsening	Phase 3	Jaeb Center for Health Research	<1 mi
A Study of Dulaglutide (LY2189265) 3.0 mg and 4.5 mg in Pediatric Participants With Type 2 Diabetes Mellitus (AWARD-PEDS PLUS)	Phase 3	Eli Lilly and Company	<1 mi
Continuous Glucose Metrics in Patients With Gastroparesis in Type 1 or Type 2 Diabetes	N/A	Samita Garg	<1 mi
Early Versus Late Adjunctive Vasopressin in Septic Shock	Phase 4	The Cleveland Clinic	<1 mi
CGM for the Early Detection and Management of Hyperglycemia in Pregnancy	N/A	Jaeb Center for Health Research	<1 mi
Bionic Pancreas in CFRD	Phase 3	Jaeb Center for Health Research	<1 mi
Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics	Early 1	Case Western Reserve University	<1 mi
GO TEAM: Glucose Optimization Through Technology Assisted Management	N/A	Sarah MacLeish	<1 mi
VK2735 for Weight Management Type 2 Diabetes Phase 3 (VANQUISH 2)	Phase 3	Viking Therapeutics, Inc.	<1 mi
Sotagliflozin to Slow Kidney Function Decline in Persons With Type 1 Diabetes and Diabetic Kidney Disease	Phase 3	Alessandro Doria	<1 mi
Investigation of Metformin in Pre-Diabetes on Atherosclerotic Cardiovascular OuTcomes	Phase 4	VA Office of Research and Development	<1 mi
A Study to Evaluate the Safety and Therapeutic Activity of GI-102 As a Single Agent and in Combination with Conventional Anti-cancer Drugs, Pembrolizumab or Trastuzumab Deruxtecan(T-DXd) in Patients with Advanced Solid Tumors (KEYNOTE-G08)	Phase 1/2	GI Innovation, Inc.	<1 mi
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease	Phase 3	Boehringer Ingelheim	12 mi
Efficacy of KL1333 in Adult Patients With Primary Mitochondrial Disease	Phase 2	Abliva AB	30 mi
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Prevention of Cardiovascular Events	N/A	Cleerly, Inc.	30 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.